Announcement under Regulation 30 (LODR)-Change in Management
Filed with BSE · · 2 pages · English
Summary by 6ix AI
This appointment was approved by the Board of Directors during their meeting held on the same day as the announcement. The filing includes details required under the SEBI regulations regarding the appointment.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Goldline Pharmaceutical Ltd. on 6ix
Earlier from Goldline Pharmaceutical
- Goldline Pharmaceutical Ltd. Press Release Jun 24 2026
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
- Goldline Pharmaceutical Ltd. Press Release Jun 09 2026
- Board Meeting Outcome for Outcome Of Board Meeting Held Today, I.E., 09Th June, 2026
- Outcome Of Board Meeting Held Today, I.E., 09Th June, 2026
Later from Goldline Pharmaceutical
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Goldline Pharmaceutical Ltd. Press Release Jul 20 2026
- Goldline Pharmaceutical Ltd. Press Release Jul 30 2026
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Goldline Pharmaceutical Ltd. Press Release Aug 07 2026
Follow Goldline Pharmaceutical into a list and get an email when it puts out news.
Follow Goldline Pharmaceutical